224 related articles for article (PubMed ID: 26938532)
1. Microarray Study of Pathway Analysis Expression Profile Associated with MicroRNA-29a with Regard to Murine Cholestatic Liver Injuries.
Li SC; Wang FS; Yang YL; Tiao MM; Chuang JH; Huang YH
Int J Mol Sci; 2016 Mar; 17(3):324. PubMed ID: 26938532
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-29a Alleviates Bile Duct Ligation Exacerbation of Hepatic Fibrosis in Mice through Epigenetic Control of Methyltransferases.
Yang YL; Wang FS; Li SC; Tiao MM; Huang YH
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106784
[TBL] [Abstract][Full Text] [Related]
3. Activation of Mir-29a in Activated Hepatic Stellate Cells Modulates Its Profibrogenic Phenotype through Inhibition of Histone Deacetylases 4.
Huang YH; Tiao MM; Huang LT; Chuang JH; Kuo KC; Yang YL; Wang FS
PLoS One; 2015; 10(8):e0136453. PubMed ID: 26305546
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-29a is a key regulon that regulates BRD4 and mitigates liver fibrosis in mice by inhibiting hepatic stellate cell activation.
Huang YH; Kuo HC; Yang YL; Wang FS
Int J Med Sci; 2019; 16(2):212-220. PubMed ID: 30745801
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-29a mitigation of endoplasmic reticulum and autophagy aberrance counteracts in obstructive jaundice-induced fibrosis in mice.
Huang YH; Yang YL; Huang FC; Tiao MM; Lin YC; Tsai MH; Wang FS
Exp Biol Med (Maywood); 2018 Jan; 243(1):13-21. PubMed ID: 29105510
[TBL] [Abstract][Full Text] [Related]
6. Exogenous Therapeutics of Microrna-29a Attenuates Development of Hepatic Fibrosis in Cholestatic Animal Model through Regulation of Phosphoinositide 3-Kinase p85 Alpha.
Yang YL; Wang FS; Lin HY; Huang YH
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32455716
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-29a mitigation of toll-like receptor 2 and 4 signaling and alleviation of obstructive jaundice-induced fibrosis in mice.
Lin YC; Wang FS; Yang YL; Chuang YT; Huang YH
Biochem Biophys Res Commun; 2018 Feb; 496(3):880-886. PubMed ID: 29366780
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-29a protects against acute liver injury in a mouse model of obstructive jaundice via inhibition of the extrinsic apoptosis pathway.
Tiao MM; Wang FS; Huang LT; Chuang JH; Kuo HC; Yang YL; Huang YH
Apoptosis; 2014 Jan; 19(1):30-41. PubMed ID: 24052410
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of miR-29a on diabetic glomerular dysfunction by modulation of DKK1/Wnt/β-catenin signaling.
Hsu YC; Chang PJ; Ho C; Huang YT; Shih YH; Wang CJ; Lin CL
Sci Rep; 2016 Jul; 6():30575. PubMed ID: 27460630
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D3 abates BDL-induced cholestasis and fibrosis in rats via regulating Hedgehog pathway.
Abdel-Rahman N; Sharawy MH; Megahed N; El-Awady MS
Toxicol Appl Pharmacol; 2019 Oct; 380():114697. PubMed ID: 31394158
[TBL] [Abstract][Full Text] [Related]
11. Pinealectomy or light exposure exacerbates biliary damage and liver fibrosis in cholestatic rats through decreased melatonin synthesis.
Chen L; Zhou T; Wu N; O'Brien A; Venter J; Ceci L; Kyritsi K; Onori P; Gaudio E; Sybenga A; Xie L; Wu C; Fabris L; Invernizzi P; Zawieja D; Liangpunsakul S; Meng F; Francis H; Alpini G; Huang Q; Glaser S
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1525-1539. PubMed ID: 30890428
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-17-5p-activated Wnt/β-catenin pathway contributes to the progression of liver fibrosis.
Yu F; Lu Z; Huang K; Wang X; Xu Z; Chen B; Dong P; Zheng J
Oncotarget; 2016 Jan; 7(1):81-93. PubMed ID: 26637809
[TBL] [Abstract][Full Text] [Related]
13. The anti-fibrotic effects of epigallocatechin-3-gallate in bile duct-ligated cholestatic rats and human hepatic stellate LX-2 cells are mediated by the PI3K/Akt/Smad pathway.
Yu DK; Zhang CX; Zhao SS; Zhang SH; Zhang H; Cai SY; Shao RG; He HW
Acta Pharmacol Sin; 2015 Apr; 36(4):473-82. PubMed ID: 25832428
[TBL] [Abstract][Full Text] [Related]
14. Mice with Hepatic Loss of the Desmosomal Protein γ-Catenin Are Prone to Cholestatic Injury and Chemical Carcinogenesis.
Zhou L; Pradhan-Sundd T; Poddar M; Singh S; Kikuchi A; Stolz DB; Shou W; Li Z; Nejak-Bowen KN; Monga SP
Am J Pathol; 2015 Dec; 185(12):3274-89. PubMed ID: 26485505
[TBL] [Abstract][Full Text] [Related]
15. Alpha-1 antitrypsin Z protein (PiZ) increases hepatic fibrosis in a murine model of cholestasis.
Mencin A; Seki E; Osawa Y; Kodama Y; De Minicis S; Knowles M; Brenner DA
Hepatology; 2007 Nov; 46(5):1443-52. PubMed ID: 17668872
[TBL] [Abstract][Full Text] [Related]
16. Loss of MMP 13 attenuates murine hepatic injury and fibrosis during cholestasis.
Uchinami H; Seki E; Brenner DA; D'Armiento J
Hepatology; 2006 Aug; 44(2):420-9. PubMed ID: 16871591
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-145 inhibits hepatic stellate cell activation and proliferation by targeting ZEB2 through Wnt/β-catenin pathway.
Zhou DD; Wang X; Wang Y; Xiang XJ; Liang ZC; Zhou Y; Xu A; Bi CH; Zhang L
Mol Immunol; 2016 Jul; 75():151-60. PubMed ID: 27289031
[TBL] [Abstract][Full Text] [Related]
18. The Role of miR-29a in the Regulation, Function, and Signaling of Liver Fibrosis.
Huang YH; Yang YL; Wang FS
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29954104
[TBL] [Abstract][Full Text] [Related]
19. PGC1α deficiency reverses cholestasis-induced liver injury via attenuating hepatic inflammation and promoting bile duct remodeling.
Li D; Ye C; Liu P; Sun T; Qin Y; Wan X
Acta Histochem; 2023 Dec; 125(8):152097. PubMed ID: 37813066
[TBL] [Abstract][Full Text] [Related]
20. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis.
Roderburg C; Urban GW; Bettermann K; Vucur M; Zimmermann H; Schmidt S; Janssen J; Koppe C; Knolle P; Castoldi M; Tacke F; Trautwein C; Luedde T
Hepatology; 2011 Jan; 53(1):209-18. PubMed ID: 20890893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
